On January 14, 2021, the NIH COVID-19 Treatment Guidelines were updated to reflect the latest studies on ivermectin. The updated recommendation was:
“The COVID-19 Treatment Guidelines Panel (the Panel) has determined that currently there are insufficient data to recommend either for or against the use of ivermectin for the treatment of COVID-19.”
That statement was a deception. A vote of the Panel to endorse that recommendation was never held.
The COVID-19 Treatment Guidelines were announced on April 21, 2020 to assist healthcare providers in treatment decisions in COVID-19. A group of 43 medical authorities and representatives of the community were assembled to produce the Guidelines. The NIH COVID-19 Treatment Guidelines are not legally binding to physicians or patients. As the Guidelines state:
“Finally, it is important to stress that the rated treatment recommendations in these Guidelines should not be considered mandates. The choice of what to do or not to do for an individual patient is ultimately decided by the patient and their provider.”
However, the Guidelines are generally considered authoritative on COVID-19 therapy. The New York Times “Coronav...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).